Intelligent medical products and systems engineering

Master your ecosystem of connected intelligent devices

MedTech companies are at different points on the journey from standalone devices to connected, intelligent products. What they share is rising complexity. Products now live inside broader ecosystems that span devices, software, data, services, and clinical workflows. Expectations are increasing, while regulatory obligations and cost pressure remain as strict as ever.

At the same time, many organizations face difficult trade‑offs: innovating faster while controlling cost, scaling digital capabilities without fragmenting quality systems, and sustaining complex products long after launch. Moving forward requires more than adding features. It requires a different way of designing, building, and sustaining products. The key is a connected, end-to-end approach. Here’s what that looks like.

Becoming an ecosystem leader

As products become connected, interoperability is everything. Devices must work with apps, platforms, EMRs, partners, and regional systems, often across multiple versions and market contexts. Integration effort adds friction that increases costs and slows growth. The defining question is: are you creating devices to fit into competitors’ ecosystems, or do you own the ecosystem?

Capgemini helps MedTech companies design and operate interoperable product ecosystems at scale. We support architectures and integration approaches that reduce complexity over time. Interoperability standards such as HL7 and FHIR are addressed pragmatically – applied where they create value – so ecosystems remain flexible, durable, and ready to evolve.

Beyond technical integration, we help organizations industrialize ecosystems globally, so intelligent products can grow without increasing operational friction.

Intelligence at the edge

In many cases, progress comes not from changing the core medical device, but from creating new systems around it – companion devices, edge platforms, or local software that add intelligence without destabilizing what has already been approved. The question then arises – in this new intelligent ecosystem, where is the intelligence? The right mix of cloud and local intelligence is crucial for balancing costs, speed and regulatory ease.

Capgemini helps MedTech companies design and implement secure, compliant edge architectures that work with existing devices and workflows. We support intelligence that runs where the work happens, whether through new edge‑based products or local systems that augment established ones. And because we own the process end to end, edge intelligence becomes part of your coherent product strategy.

This includes edge AI and compact models embedded directly in devices, companion applications that extend approved products, and intelligent connectivity layers that enable real‑time insight while remaining compliant with regulated change management.

Sustenance and modernization as a growth lever

For many MedTech companies, immense opportunity lies in the installed base. In the fast-changing field of medical technology, legacy and capital equipment are easy to overlook. But with the right investment, they have the potential to deliver significant clinical and commercial value.

Capgemini approaches product sustenance and modernization as a strategic capability. We help organizations evolve software, connectivity, and analytics over time, improving outcomes and extending product lifecycles. Sustenance becomes a platform for growth. Modernization is delivered without disrupting regulatory approvals, enabling intelligent upgrades, cost optimization, and long‑term availability for products deployed in demanding healthcare environments.

Security by design

Connected products expand the attack surface, from constrained devices at the edge to cloud platforms and data flows across regions. Adding security as an afterthought raises costs, while disrupting products, timelines, and trust.

Capgemini embeds cybersecurity into intelligent medical products from the start. Security is designed across device, network, and cloud, with a clear view of practical business risk rather than theoretical threat models. This helps organizations protect patients, data, and operations while supporting faster innovation and smoother regulatory interactions.

Security and privacy are addressed together, with governance models that support data protection, regional requirements, and secure operation across the full ecosystem lifecycle.

From regulated development to lifecycle support

Intelligent medical products demand rigorous development and testing. Software transformation, SaMD/DTx solutions, and platform engineering must meet the same standards of reliability and compliance as physical devices.

Capgemini supports regulated medical device development end to end, from R&D through post‑market. IMPS/SaMD accelerators support faster, more predictable development of software‑driven products, while legal manufacturer readiness helps organizations operate confidently in regulated markets. We support long‑term post‑market operation, helping organizations manage change, sustain compliance, and operate intelligent products reliably over extended lifecycles.

Why Capgemini

Capgemini supports your success across the full lifecycle of intelligent medical products. From early engineering decisions to post market operation, we help organizations move forward with coordination and confidence. Our role is to reduce complexity, build value, and help intelligent products deliver lasting impact in real healthcare environments.

What differentiates Capgemini is our ability to combine scale, regulatory depth, and end‑to‑end ownership. At every stage of production – from innovation, through industrialization, to release and beyond – your intelligent products gain the strategic edge they need for success.

Contact us below to discuss where you are on your intelligent product journey, and where you want to go next.